section name header

Basics

Outline


BASICS

Definition!!navigator!!

Gradually progressive, symmetric muscular weakness in horses characterized by flaccid paralysis and dysphagia.

Pathophysiology!!navigator!!

  • Systemic absorption of the Clostridium botulinum neurotoxin inhibits acetylcholine release at the neuromuscular junction, leading to flaccid paralysis
  • After toxin absorption from the digestive tract or infected wounds, botulinum toxin circulates in the bloodstream and, subsequently, is bound by specific endopeptidase receptors on motor end plates. Once attached to the receptor, the toxin is translocated within the cell and bound to acetylcholine vesicles, preventing electrical signals from reaching the myoneural junctions
  • With relatively small doses of toxin, clinical signs may not become apparent for 10 days after ingestion. However, horses may become recumbent and die within 8 h with massive doses
  • Botulism spores are relatively ubiquitous in the environment. Ingestion rarely leads to clinical botulism, however, because the spores do not elaborate toxin unless present in an anaerobic environment with a high pH and appropriate nutrients
  • Botulism spores are pH sensitive and do not form toxin at pH < 4.5
  • Three forms of the disease are recognized in horses. The most common in adult horses is ingestion of the preformed toxin. Young foals develop toxicoinfectious botulism through ingestion of spores and subsequent sporulation with toxin formation in the gut. Toxin elaboration can also occur in wounds such as castration sites and deep penetrating wounds, including deep IM injections (wound botulism)

Systems Affected!!navigator!!

Neuromuscular

  • Progressive muscular weakness over several hours to days frequently manifests as trembling of the larger muscle groups, especially triceps and gluteals
  • As clinical signs progress, affected horses lie down more frequently than normal and may become unable to stand. They may struggle to stand, get up and stand for several minutes, then lie down, at first in sternal recumbency, then later lateral recumbency
  • Slow chewing and dysphagia may be seen in adult horses. Drooling and feed at the nostrils may also be noted due to difficulty swallowing
  • Affected foals attempt to suckle the mare, but milk drools from the foal's mouth

GI

Colic may be the primary sign prior to showing weakness. Intestinal ileus is common.

Respiratory

Respiratory distress during the terminal phases of botulism. Secondary aspiration pneumonia possible.

Ophthalmic

Moderate mydriasis with intact pupillary light reflex.

Renal/Urologic

  • Horses that remain standing can void the bladder, which helps to differentiate botulism from herpesvirus infections
  • Down horses will retain urine in the bladder, requiring periodic catheterization

Cardiovascular

Tachycardia and cardiac arrhythmia may be present independently of stress or dehydration.

Incidence/Prevalence!!navigator!!

Type B

  • More than 85% of equine botulism cases in the USA
  • Most frequently occurs in the mid-Atlantic region in North America
  • May occurs as an individual or multiple cases
  • Several cases occurring over a few days suggests a point source of toxin such as silage (haylage) or spoiled hay from large hay bales

Type A

Typically occurs in the western USA, especially in Idaho, Utah, and California.

Type C

  • May occur when a decomposing carcass contaminates feed materials
  • More common in Arizona and New Mexico

Signalment!!navigator!!

Mean Age and Range

  • Foals—peak occurrence between 6 days and 6 weeks of age
  • Adults—any age

Signs!!navigator!!

Historical Findings

  • Generalized muscle weakness or dysphagia typically is the first clinical sign detected
  • Astute owners also may detect mild depression, decreased exercise tolerance, and reluctance to eat hay or grain

Physical Examination Findings

  • Generalized muscle weakness, with early signs being toe-dragging, decreased tail tone, eyelid tone, and tongue tone
  • A “grain test” can be used to assess for early dysphagia. Most normal horses should be able to consume 225 mL (8 oz) of grain within 2 min
  • As the disease progresses, dysphagia becomes more obvious, and muscular weakness may progress to the point of recumbency and respiratory paralysis
  • Vital signs are normal during the early stages of disease. Once the horse is recumbent, however, both the heart and respiratory rate increase in proportion to the intensity of the struggle to rise
  • Borborygmus sounds are typically reduced

Causes!!navigator!!

  • The source of toxin in most cases of individual equine botulism is rarely determined but most likely is ingestion of a small amount of preformed toxin in roughage (typically hay). It is often impossible to subsequently identify toxin in roughage samples, because the offending material has been consumed
  • In herd outbreaks, the point source is most often hay in plastic bags or round bales
  • Rarely has commercial grain been associated with equine botulism
  • Roughage contaminated with a carcass typically results in type C botulism
  • Wound botulism may develop secondary to infected castration sites, clamped umbilical hernias, and deep IM injections with counterirritants—iodine preparations

Risk Factors!!navigator!!

  • Feed sources—silage or fermented forages
  • Foals from unvaccinated mares in endemic areas are at risk of toxicoinfectious botulism

Diagnosis

Outline


DIAGNOSIS

Differential Diagnosis!!navigator!!

  • Equine herpes myeloencephalopathy, atypical myopathy, hyperkalemic periodic paralysis, equine motor neuron disease, West Nile virus
  • Toxins—ionophores, organophosphates
  • Equine protozoal myelitis and guttural pouch mycosis (dysphagia)
  • Neonatal foals—generalized weakness due to sepsis or white muscle disease

CBC/Biochemistry/Urinalysis!!navigator!!

Until affected horses are recumbent, CBC and biochemistry profiles are within normal limits.

Other Laboratory Tests!!navigator!!

  • An arterial blood gas is needed to diagnose hypercapnia and hypoxemia, and can help determine the need for mechanical ventilation in foals
  • Electromyography is not often used but should show abundant small amplitude action potentials in the face of flaccid paralysis

Diagnostic Procedures!!navigator!!

  • Identification of toxin or spores in feed materials or GI contents via mouse bioassay has been considered the gold standard for testing, but these tests may take as long as 2–4 weeks to complete. In addition horses appear to be more sensitive to the toxin than mice, and levels detrimental to horses may not harm mice
  • PCR for detection of botulism neurotoxin in feces, GI content, or feed has been shown to be sensitive and specific, and provides more rapid and cost-effective testing than the mouse bioassay
  • Diagnosis is most often based on clinical signs and ruling out other causes of dysphagia or weakness. Treatment with antitoxin should not be delayed in suspected cases of botulism

Pathologic Findings!!navigator!!

Lack of gross and histologic lesions typifies horses with botulism.

Treatment

Outline


TREATMENT

Appropriate Health Care!!navigator!!

Confine affected horses to a box stall with no additional physical activity. Inpatient hospitalization is recommended.

Nursing Care!!navigator!!

  • Provide soups made with pelleted complete feed in a low ridge bucket placed on the ground if horses are not recumbent
  • Enteral fluid therapy may be required in horses with complete dysphagia
  • Enteral nutrition can be provided via nasogastric feeding tube. Powdered or blenderized pelleted complete feeds can be used
  • Neonates should be fed mare's milk every 2 h
  • For horses that are unable to sit sternal, IV fluids and parenteral nutrition may be used to reduce the risk of aspiration
  • Recumbent horses require an immense amount of nursing care to minimize decubital sores and other complications
  • Recumbent horses, especially males, may need to have their bladder catheterized periodically
  • Mechanical ventilation should be used in foals with signs of respiratory fatigue or failure

Activity!!navigator!!

  • Restriction of any muscular activity of affected horses is critical
  • Assistance manually or with a sling to rise from recumbency or turn to opposite recumbency 4 times/day. Maintain recumbent horses in sternal position if possible
  • Slings should be used with caution as the stress of slinging may hasten death
  • Horses that struggle excessively when down or remain down for more than 24 h have very poor prognosis for survival

Client Education!!navigator!!

  • Once botulism has occurred on a farm, annual vaccination of all horses on the farm is strongly recommended every year
  • Vaccination of horses prior to feeding with silage (haylage) is advised in high-risk regions.
  • After the occurrence of botulism in one horse, owners should be very diligent for signs in other horses

Medications

Outline


MEDICATIONS

Drug(s) of Choice!!navigator!!

  • Multivalent botulinum antitoxin administered soon after the onset of clinical signs is critical. Monovalent (type B) antitoxin is also commercially available and is appropriate for treating horses in the eastern USA and Canada
  • Antitoxin will not reverse clinical signs at it will not neutralize unbound toxin. Antitoxin should stop progression of the disease and allow patients to improve by growing more motor end plates at the myoneural junctions
  • Crystalline penicillin or metronidazole may be used in cases of wound botulism. Broad-spectrum antimicrobials are indicated for treatment of aspiration pneumonia when present
  • Laxatives such as mineral oil may be needed to treat horses with GI ileus

Contraindications!!navigator!!

  • Aminoglycosides, procaine penicillin, and tetracycline are contraindicated due to their interference at the neuromuscular junction.
  • Penicillins and metronidazole, although useful for treatment of the botulism organisms, may also contribute to a reduction in normal GI flora and subsequent overgrowth of C. botulinum

Follow-up

Outline


FOLLOW-UP

Patient Monitoring!!navigator!!

  • Monitor hydration status and ventilation. Respiratory fatigue and aspiration pneumonia can rapidly lead to respiratory distress
  • Mild improvement in strength and swallowing function may be seen as early as 1 week, but full recovery is not expected for at least 1 month

Prevention/Avoidance!!navigator!!

  • 3 doses of monovalent type B botulinum toxoid 4 weeks apart are recommended to provide the most complete protection
  • Annual revaccination with a single dose of toxoid is adequate to maintain effective protection
  • Adequately vaccinated mares provide passive protection to newborn foals for several weeks if colostral ingestion is adequate. Mares should be vaccinated 4–6 weeks before foaling
  • Foals of unvaccinated mares can be vaccinated within the first 2–3 weeks of life

Possible Complications!!navigator!!

  • Aspiration pneumonia secondary to dysphagia is a concern, but many horses recover without intensive antibiotic therapy
  • Ventilatory failure will lead to death in adults, and requires mechanical ventilation in foals
  • Massive decubital sores may result from recumbency in adults with botulism

Expected Course and Prognosis!!navigator!!

  • The more rapid the onset of clinical signs, the poorer is the prognosis for survival
  • Overall survival rate in adults is approximately 50%, with poor chance of survival in horses that lost the ability to stand
  • Once given the antitoxin, horses remain stable for 2–4 days and then gradually improve during the next 5–10 days as they regain their ability to swallow both water and roughage. Muscle strength gradually returns during the next 30 days. Weak tongues may persist for several weeks, but affected horses seem to eat and swallow normally
  • Foals are reported to have a better prognosis (>96% for treated foals), although 30% required mechanical ventilation

Miscellaneous

Outline


MISCELLANEOUS

Synonyms!!navigator!!

  • Forage poisoning in adults
  • Shaker foal syndrome

Abbreviations!!navigator!!

  • GI = gastrointestinal
  • PCR = polymerase chain reaction

Suggested Reading

Johnson AL, McAdama-Gallagher SC, Aceto H. Outcome of adult horses with botulism treated at a veterinary hospital: 92 cases (1989-2013). J Vet Intern Med 2015;29:311319.

Johnson AL, McAdama-Gallagher SC, Aceto H. Accuracy of a mouse bioassay for the diagnosis of botulism in horses. J Vet Intern Med 2016;30:12931299.

Stratford CH, Mayhew IG, Hudson NPH. Equine botulism: a clinical approach to diagnosis and management. Equine Vet Educ 2014;26:441448.

Wilkins PA, Palmer JE. Botulism in foals less than 6 months of age: 30 cases (1989–2002). J Vet Intern Med 2003;17:702707.

Author(s)

Author: Margaret C. Mudge

Consulting Editor: Caroline N. Hahn